You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ebola viruses

Showing 1 - 25 of 972
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ebola Virus Disease Trial in Decatur (Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV?G-ZEBOV-GP))

Not yet recruiting
  • Ebola Virus Disease
  • Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)
  • Decatur, Georgia
    The Hope Clinic of the Emory Vaccine Center
Oct 20, 2023

Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)

Completed
  • Ebola Virus Disease
  • Marburg Virus Disease
  • cAd3-Marburg
  • cAd3-EBO-S
  • Oklahoma City, Oklahoma
    Oklahoma Blood Institute (OBI)
Aug 2, 2022

Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)

Completed
  • Ebola Virus Disease
  • Ad26.ZEBOV vaccine
  • Boende, Province De La Tshuapa, Congo, The Democratic Republic of the
    Hôpital Général de Référence de Boende
Jan 3, 2023

Ebola Virus Disease Trial in Kinshasa (Ad26.ZEBOV, MVA-BN-Filo vaccine)

Active, not recruiting
  • Ebola Virus Disease
  • Ad26.ZEBOV, MVA-BN-Filo vaccine
  • Kinshasa, Congo, The Democratic Republic of the
    L'Institut National de Recherche Biomédicale RDC
Nov 15, 2021

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Not yet recruiting
  • Warts
  • Detection of expression of SOCS3 gene
  • +2 more
  • (no location specified)
Mar 12, 2023

Covid-19, Nosocomial Infection, Coronavirus Trial in London (Use of virus (Covid-19) genome sequence report to inform infection

Completed
  • Covid-19
  • +4 more
  • Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures
  • London, United Kingdom
    University College London Hospitals NHS Foundation Trust
Feb 16, 2022

Hemorrhagic Fever, Ebola Trial in Worldwide (Ad26.ZEBOV, MVA-BN-Filo, Placebo)

Completed
Has Results
  • Hemorrhagic Fever, Ebola
  • Ad26.ZEBOV
  • +2 more
  • BoboDioulasso, Burkina Faso
  • +6 more
Feb 9, 2022

Hemorrhagic Fever, Ebola Trial in Worldwide (Ad26.ZEBOV, MVA-BN-Filo, Placebo)

Completed
Has Results
  • Hemorrhagic Fever, Ebola
  • Ad26.ZEBOV
  • +2 more
  • Silver Spring, Maryland
  • +6 more
Jan 27, 2022

Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)

Not yet recruiting
  • Sudan Ebola Virus Vaccines
  • CAd3
  • +3 more
  • (no location specified)
Jun 8, 2023

Ebola Virus Disease Trial in Kampala (Ebola+D intervention)

Recruiting
  • Ebola Virus Disease
  • Ebola+D intervention
  • Kampala, Uganda
    Mubende Regional Referal Hospital
Oct 19, 2023

SARS-CoV 2, COVID-19 Trial in Manama (plasma therapy using convalescent plasma with antibody against SARS-CoV-2, Routine care

Completed
  • SARS-CoV 2
  • COVID-19
  • plasma therapy using convalescent plasma with antibody against SARS-CoV-2
  • Routine care for COVID-19 patients
  • Manama, Bahrain
    Royal College of Surgeons in Ireland - Bahrain
Oct 25, 2021

Host Genetic Factors Underlying Ebola Virus Disease Risk,

Completed
  • Ebola Virus Disease
    • Kalkata, Liberia
    • +3 more
    Aug 18, 2022

    Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)

    Completed
    Has Results
    • Ebola Virus
    • cAd3-EBO S vaccine
    • Kampala, Uganda
      Makerere University-Walter Reed Project
    Nov 10, 2022

    Readiness for Ebola Vaccination in Liberia

    Not yet recruiting
    • Ebola Virus Disease
    • Community Clusters
    • Monrovia, Montserrado County, Liberia
      Montserrado, Margibi and Lofa Counties
    May 24, 2023

    Congenital Heart Disease, Viremia, Virus Diseases Trial in Saint Louis (Stool and Blood Specimen Collection, Follow-up Medical

    Recruiting
    • Congenital Heart Disease
    • +14 more
    • Stool and Blood Specimen Collection
    • Follow-up Medical Record Review
    • Saint Louis, Missouri
    • +1 more
    Aug 2, 2022

    Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)

    Not yet recruiting
    • Ebola Virus Disease
    • Zabdeno® booster
    • Ervebo® booster
    • Goma, Congo, The Democratic Republic of the
    • +1 more
    Nov 6, 2023

    SARS-CoV-2 Infection, Cognitive Disorder Trial in Paris (Nasopharyngeal swab for RT-PCR SARS-CoV-2)

    Recruiting
    • SARS-CoV-2 Infection
    • Cognitive Disorder
    • Nasopharyngeal swab for RT-PCR SARS-CoV-2
    • Paris, France
    • +1 more
    Jul 18, 2022

    After Immunisation With Ebola Virus Vaccines

    Completed
    • Ebola Virus Disease
    • Previously exposed to Ebola vaccine
    • Glasgow, United Kingdom
    • +1 more
    Jul 14, 2020

    Healthy Volunteers Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rVSV-Zebov GP vaccine)

    Active, not recruiting
    • Healthy Volunteers
    • rVSV-Zebov GP vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 7, 2023

    Convalescent Plasma for COVID 19 Trial in Saudi Arabia (convalescent plasma from recovered COVID 19 donor)

    Completed
    • Convalescent Plasma for COVID 19
    • convalescent plasma from recovered COVID 19 donor
    • Dhahran, Eastern Provence, Saudi Arabia
    • +13 more
    Nov 14, 2021

    Healthy Trial in Cuangugu, Gysenyi, Kigali (Ad26.ZEBOV, MVA-BN-Filo)

    Active, not recruiting
    • Healthy
    • Ad26.ZEBOV
    • MVA-BN-Filo
    • Cuangugu, Rwanda
    • +2 more
    Jan 17, 2023

    Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))

    Not yet recruiting
    • Ebola Virus Disease
    • rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
    • Kenema, Eastern, Sierra Leone
      Kenema Government Hospital
    Aug 7, 2023

    Severe Infectious Diseases (CCPSEI)

    Completed
    • Coronavirus
      • Baltimore, Maryland
        Johns Hopkins Hospital
      Jan 13, 2022

      French COVID Cohort

      Recruiting
      • Coronavirus Infections
        • Agen, France
        • +97 more
        Feb 24, 2022

        Ocular Infection, Viral Trial in Nashville

        Completed
        • Ocular Infection, Viral
          • Nashville, Tennessee
            Vanderbilt University Medical Center
          Mar 22, 2022